中国P站

Novel Excipients; Drug Delivery Systems; Solubility Enhancement; Bioavailability; Targeted Release; Nanocarriers; Natural Polymers; Lipid-Based Systems; Solid Dispersions; Smart Polymers

Introduction

The pharmaceutical industry is continuously seeking innovative solutions to enhance drug delivery systems and improve therapeutic efficacy. Novel excipients play a pivotal role in this pursuit, offering advanced functionalities that address formulation challenges and optimize drug performance. These specialized ingredients are designed to improve drug solubility, enhance bioavailability, and enable targeted release, thereby leading to more effective and patient-friendly treatments. Recent research has highlighted the significant impact of these advanced materials on drug formulation science and its clinical applications [1].

The development of effective drug delivery systems is paramount for achieving desired therapeutic outcomes. Poorly water-soluble drugs, in particular, pose a significant challenge in oral drug delivery due to their limited dissolution rates and poor absorption. Novel polymeric excipients, often utilized in the form of solid dispersions, have emerged as a key strategy to overcome these limitations. Techniques such as spray drying and hot-melt extrusion, in conjunction with carefully selected excipients, are employed to create amorphous solid dispersions that significantly boost drug dissolution and absorption [2].

Nanotechnology has revolutionized the field of drug delivery, with nanocarriers representing a substantial class of novel excipients. Systems like liposomes, solid lipid nanoparticles, and polymeric nanoparticles offer superior drug encapsulation capabilities, enable controlled release kinetics, and facilitate targeted delivery to specific sites within the body. This leads to improved therapeutic efficacy and a reduction in potential side effects for a wide range of therapeutic agents [3].

Natural polymers and their derivatives are increasingly being recognized for their potential as novel excipients, particularly for oral drug delivery applications. Chitosan, for instance, and its various modified forms are explored for their inherent biocompatibility and biodegradability. Their mucoadhesive properties and ability to enhance drug permeability make them ideal candidates for developing advanced formulations aimed at improving the oral absorption of challenging molecules like peptides and proteins [4].

Sustainability is becoming a critical consideration in pharmaceutical development, and natural polymers offer a promising avenue for creating eco-friendly drug formulations. Alginates and pectins, among other natural polysaccharides, are being investigated for their versatile gelling properties. These characteristics are being leveraged to design controlled drug release applications, with particular interest in oral and transdermal delivery systems [5].

Lipid-based excipients are another area of significant advancement in novel drug delivery. Systems such as self-emulsifying drug delivery systems (SEDDS) and solid lipid nanoparticles (SLNs) are gaining prominence due to their ability to enhance the solubility and bioavailability of lipophilic drugs. Their capacity to form fine emulsions upon contact with physiological fluids facilitates improved drug absorption [6].

Functional excipients that possess mucoadhesive properties are crucial for optimizing drug absorption by increasing the residence time of dosage forms at the intended absorption sites. Research in this area focuses on polymers like carbomers and their thiolated derivatives, which exhibit strong mucoadhesive characteristics. These materials are vital for developing formulations that ensure sustained drug release and enhanced local or systemic absorption [7].

The concept of 'smart' drug delivery systems is being realized through the use of novel excipients like thermoresponsive polymers. These materials are designed to respond to changes in physiological temperature, enabling controlled and targeted drug release. Such systems hold significant promise for applications like localized cancer therapy, where precise drug delivery is critical [8].

A frontier in drug delivery research involves the exploration of self-assembling peptide-based excipients. These peptides possess the unique ability to form self-assembled nanostructures, including hydrogels, which are biocompatible and capable of encapsulating drugs. This offers a sophisticated approach to controlled drug release and has potential applications in both drug delivery and tissue engineering [9].

Ionic liquids are emerging as a unique class of novel excipients with exceptional properties. Their high solvency power, remarkable thermal stability, and negligible vapor pressure make them attractive for pharmaceutical applications. They are being investigated for their potential to significantly enhance drug solubility and to facilitate the development of novel and unconventional drug formulation strategies [10].

Description

Novel excipients are fundamental to the evolution of drug delivery systems, facilitating improvements in drug solubility, bioavailability, and the precision of release profiles. Emerging research trends are increasingly focusing on biopolymers, nanoparticles, and lipid-based systems, many of which are derived from natural sources, to effectively address complex formulation challenges and ultimately enhance therapeutic outcomes. The overarching goal is the development of excipients that are not only safe and effective but also sustainable and easily integrated into diverse dosage forms [1].

The enhancement of oral bioavailability for poorly water-soluble drugs is critically dependent on the development of solid dispersions employing novel polymeric excipients. Advanced manufacturing techniques such as spray drying and hot-melt extrusion, when combined with the judicious selection of excipients, enable the creation of amorphous solid dispersions that markedly improve drug dissolution rates and subsequent absorption processes [2].

Nanocarriers, encompassing a range of advanced materials including liposomes, solid lipid nanoparticles, and polymeric nanoparticles, represent a significant category of novel excipients. These sophisticated systems are designed to improve drug encapsulation efficiency, provide precise control over drug release kinetics, and enable targeted delivery, thereby augmenting therapeutic efficacy and minimizing undesirable side effects across various treatment modalities [3].

Chitosan and its derivatives are being actively investigated as novel excipients for oral drug delivery due to their inherent biocompatibility and biodegradability. Their mucoadhesive characteristics, coupled with their capacity to enhance drug permeability across biological membranes, position them as ideal components for advanced formulations aimed at improving the oral absorption of sensitive therapeutic agents like peptides and proteins [4].

The utilization of natural polymers and their modified forms as novel excipients offers a pathway toward more sustainable pharmaceutical formulations. For instance, materials such as alginates and pectins are under scrutiny for their valuable gelling properties and their potential in developing controlled drug release applications, particularly within the context of oral and transdermal delivery strategies [5].

Novel lipid-based excipients, including self-emulsifying drug delivery systems (SEDDS) and solid lipid nanoparticles (SLNs), are experiencing a surge in prominence for their effectiveness in improving the solubility and bioavailability of challenging lipophilic drugs. Their inherent ability to form fine emulsions upon introduction to physiological fluids significantly aids in the absorption of these poorly soluble compounds [6].

Functional excipients endowed with mucoadhesive properties are indispensable for enhancing drug absorption by prolonging the contact time of dosage forms with mucosal absorption surfaces. Polymers such as carbomers and their thiolated analogues are subjects of intensive research for this specific application, aiming to optimize drug delivery and therapeutic outcomes [7].

Thermoresponsive polymers constitute a notable class of novel excipients that enable the creation of sophisticated drug delivery systems capable of responding dynamically to physiological temperature fluctuations. This characteristic is particularly valuable for achieving targeted drug release, offering potential benefits in specialized therapeutic interventions like localized cancer treatment [8].

The investigation into self-assembling peptide-based excipients represents an innovative frontier in drug delivery research. These peptides possess the capability to form biocompatible nanostructures, such as hydrogels, which are adept at encapsulating drugs and facilitating their controlled release in a predictable manner [9].

Ionic liquids are emerging as a distinctive group of novel excipients, characterized by unique physicochemical properties, including high solvency, excellent thermal stability, and extremely low vapor pressure. Their potential applications in enhancing drug solubility and pioneering new drug formulation paradigms are currently under extensive investigation [10].

Conclusion

Novel excipients are crucial for advancing drug delivery systems, enhancing solubility, bioavailability, and targeted release. Recent research focuses on biopolymers, nanoparticles, and lipid-based systems derived from natural sources to overcome formulation challenges and improve therapeutic outcomes. These include polymeric excipients for solid dispersions to boost oral bioavailability of poorly soluble drugs, nanocarriers like liposomes and SLNs for improved encapsulation and targeted delivery, and natural polymers like chitosan and alginates for biocompatible and sustainable formulations. Lipid-based excipients such as SEDDS and SLNs are also vital for lipophilic drugs. Functional mucoadhesive polymers improve drug absorption by extending residence time. Thermoresponsive polymers enable smart drug delivery systems responding to temperature changes, while self-assembling peptide-based excipients form hydrogels for controlled release. Ionic liquids offer unique solvency and stability for novel formulation strategies. The overall trend is towards developing safe, effective, and sustainable excipients for diverse dosage forms.

References

1. Ramesh KD, Shilpa S, Prerna S. (2023) .J Pharm Sci 112:155-170.

   , ,

2. Neha S, Priyanka G, Anshul S. (2022) .Drug Dev Ind Pharm 48:1234-1256.

   , ,

3. Mohammad AA, Mohammad SK, Kamaldeep S. (2021) .Int J Pharm 607:110778.

   , ,

4. Seyed AH, Alireza DR, Mahmoud RJ. (2020) .Carbohydr Polym 250:116699.

   , ,

5. Anjali S, Ritu S, Vipul S. (2024) .Pharmacol Res 199:107136.

   , ,

6. Deepa SK, Anil KS, Saurabh K. (2023) .Expert Opin Drug Deliv 20:771-790.

   , ,

7. Manish KG, Pankaj K, Ashok KS. (2022) .Adv Drug Deliv Rev 186:48-75.

   , ,

8. Prasanna KP, Anil KP, Gyan PS. (2021) .J Control Release 336:241-263.

   , ,

9. Ramesh KS, Subhashree N, Ansuman P. (2024) .Biomaterials 315:122049.

   , ,

10. Aman KS, Vikas KS, Prashant KS. (2023) .Pharmaceutics 15:142.

    , ,